Get Your Personalized Supplement StackSupplement Stack Quiz

Lobelia Aerial Parts Extract

Also known as: Lobelia inflata, Lobelia pyramidalis, Lobelia chinensis, Lobelia tupa, Indian tobacco, Lobelia

Overview

Lobelia aerial parts extract is derived from the above-ground parts (leaves, stems, flowers) of various *Lobelia* species, most commonly *Lobelia inflata*. It is rich in alkaloids, particularly lobeline, and also contains other bioactive compounds such as flavonoids and essential oils. Traditionally, it has been used for respiratory ailments like asthma, bronchitis, and pneumonia due to its purported expectorant and bronchodilator effects. Research has also explored its potential in mood disorders and for its antimicrobial properties. While extensive preclinical studies and phytochemical analyses exist, high-quality human clinical trials are limited. The evidence base is primarily composed of in vitro and animal studies, with few rigorous randomized controlled trials in humans, indicating a moderate level of research maturity but a need for more robust clinical validation.

Benefits

Lobelia aerial parts extract has shown several potential benefits, primarily in preclinical settings. Its main proposed effect is respiratory support, where lobeline acts as a respiratory stimulant and expectorant. Animal studies suggest it may relax airways and aid in clearing mucus, with some research indicating reduced lung inflammation and injury. Additionally, essential oils from species like *Lobelia pyramidalis* have demonstrated moderate antimicrobial activity against various pathogens in vitro. Beyond respiratory effects, lobeline and related alkaloids exhibit neuropharmacological properties by modulating nicotinic acetylcholine receptors (nAChRs), showing partial agonist activity. This has led to investigations into its potential antidepressant-like effects in animal models. However, it is crucial to note that there is no robust human clinical data to confirm these benefits in specific populations, and effect sizes and clinical significance remain unestablished in humans due to the lack of randomized controlled trials. Animal study findings, while significant biochemically and behaviorally, cannot be directly extrapolated to human efficacy.

How it works

The primary mechanism of action for Lobelia aerial parts extract revolves around its alkaloid content, particularly lobeline. Lobeline and related alkaloids function as partial agonists at various nicotinic acetylcholine receptor (nAChR) subtypes, including α7, α3β2, and α3β4. By interacting with these receptors, lobeline influences neurotransmission and respiratory reflexes. It is believed to modulate central nervous system receptors involved in mood and addiction, and to stimulate respiratory centers, leading to airway smooth muscle relaxation. The antimicrobial effects observed are likely attributable to the essential oil constituents, which may disrupt microbial membranes. While lobeline has moderate bioavailability, its therapeutic index is narrow, meaning the effective dose is close to the toxic dose, which is a significant safety consideration.

Side effects

Lobelia aerial parts extract has a narrow therapeutic index, meaning there is a small difference between effective and toxic doses, leading to a significant potential for toxicity at higher doses. Common side effects, primarily due to its nicotinic effects, include gastrointestinal upset, nausea, and vomiting. Less common side effects (occurring in 1-5% of users) can include choking, cough, and dizziness. Rare but severe side effects, including lethal toxicity, have been reported in overdose cases. Due to its stimulant effects, Lobelia is contraindicated in pregnancy, breastfeeding, individuals with cardiovascular disease, and those with seizure disorders. It also has potential interactions with other nicotinic agents, CNS stimulants, and respiratory drugs, necessitating caution when used concurrently. Children and the elderly are considered at higher risk for adverse effects, and there is insufficient data to support safe use in these populations.

Dosage

There is no standardized or clinically validated dosing for Lobelia aerial parts extract due to the lack of high-quality human clinical trials. The minimum effective dose is not well established, and historical herbal doses, which can range from 20-60 mg of lobeline equivalent daily, are not clinically validated and carry significant safety concerns. The maximum safe dose has a narrow margin, and overdose risks are significant. Lobelia is typically administered orally, but the timing relative to symptoms is not standardized. For consistency, extracts standardized to lobeline content are preferred. However, detailed pharmacokinetic data regarding absorption and bioavailability are limited, and no specific cofactors are established to enhance its effects or safety. Due to its narrow therapeutic index and potential for toxicity, any use should be approached with extreme caution and under professional supervision.

FAQs

Is Lobelia aerial parts extract safe?

Lobelia has a narrow safety margin with potential for toxicity, especially at higher doses. It should be used with extreme caution and only under professional supervision due to its significant side effects and overdose risks.

Does it work for asthma?

Animal studies suggest potential benefits for respiratory conditions like asthma by relaxing airways. However, there are no human randomized controlled trials to confirm its efficacy or safety for asthma in people.

Can it be used for depression?

Preclinical evidence indicates possible antidepressant-like effects in animal models due to its interaction with nicotinic receptors. However, there are no clinical trials supporting its use for depression in humans.

How quickly does it act?

The time course of benefits in humans is unknown. Animal studies have shown effects within hours to days, but this cannot be directly extrapolated to human response times.

Is it addictive?

While lobeline acts on nicotinic receptors, it is not known to be addictive in the same way as nicotine. However, safety concerns and potential toxicity significantly limit its use.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC5611621/ – This study conducted a phytochemical analysis of *Lobelia pyramidalis* essential oil, identifying 21 constituents. It also demonstrated moderate in vitro antimicrobial activity against various pathogens, suggesting potential therapeutic applications for the plant's essential oil.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.638210/pdf – This review synthesizes over 610 studies on lobeline and its analogs, highlighting lobeline's role as a partial agonist at nicotinic acetylcholine receptors. It emphasizes the narrow therapeutic index and toxicity concerns associated with lobeline, while also identifying novel alkaloids with similar receptor activity.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7982472/ – This source, likely a review or summary, discusses bioactive compounds from *Lobelia* species, focusing on lobeline and its pharmacological properties. It reiterates lobeline's partial agonist activity at nAChRs and notes its toxicity and narrow therapeutic index, consistent with other research on the compound.
https://www.healthline.com/nutrition/lobelia – This narrative review references animal studies suggesting that lobeline may reduce lung injury and exhibit antidepressant-like behaviors in mice. It acknowledges the lack of human clinical trials, indicating that the evidence for these effects is primarily preclinical and indirect.
https://www.drugs.com/npp/lobelia.html – This source provides a general overview of Lobelia, including its traditional uses and known pharmacological properties. It likely summarizes information on its active compounds, potential benefits, and importantly, its safety concerns, aligning with the narrow therapeutic index and toxicity warnings found in scientific literature.